| Application no. and date | 20739655.7 (espacenet) (Federated) (European Patent Register), 20200710 | | Patent/reg. no. and date | DK/EP 3996679, 20230906 | | Publication date | 20220518 | | Priority no. and date | EP 19185958, 20190712 | | EP pub. no. and date |
EP 3996679 20220518 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | HAVELUND, Svend, Novo Allé, 2880 Bagsværd, DK,
STURIS, Jeppe, Novo Allé, 2880 Bagsværd, DK,
PEDERSEN, Karen-Margrethe, Novo Allé, 2880 Bagsværd, DK | | Representative | | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 9/08 (2006.01) , A61P 3/10 (2006.01) | | Title | HIGH CONCENTRATION INSULIN FORMULATION | | Int. application no. | EP2020069512 | | Int. publication no. | WO2021009027 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
